Introduction

This report offers an in-depth exploration of digital health innovation in cardiovascular care, highlighting the cutting-edge trends, technologies, and partnerships that are transforming heart health. From AI-powered diagnostics to targeted interventions for hypertension, this analysis reveals how trailblazing startups and evidence-driven ventures are reshaping patient outcomes and establishing global partnerships. Despite recent funding challenges, cardiovascular digital health remains resilient, delivering impactful solutions for one of the world’s most pressing health concerns.

Key insights include strong funding activity in cardiovascular digital health, with the sector ranking among the top five funded areas, though venture investment fell by 45% year-over-year. Specific areas like hypertension are leading the way, and AI integration is growing, with 56% of cardiovascular digital health solutions now leveraging AI technology. Partnerships in the sector are also robust, with cardiovascular ventures securing a notable share of global digital health alliances. Finally, nearly half of the ventures in this space demonstrate significant evidence of improving patient outcomes, solidifying cardiovascular digital health as a critical area for innovation in healthcare.

Key insights from the report

1. Digital Health Funding in Cardiovascular Care: Cardiovascular digital health solutions rank among the top five funded areas, even as venture funding for these technologies fell by 45% year-over-year. To date in 2024, $1.2 billion has been invested in this sector.
2. Hypertension Leads in Cardiovascular Digital Health: Hypertension solutions dominate cardiovascular-focused digital health, with over 160 startups launched since 2019, securing $4.2 billion in total funding. Hypertension-focused ventures account for 23% of all cardiovascular startups.
3. AI Integration in Cardiovascular Digital Health: AI technology powers 56% of cardiovascular digital health solutions, with 4% utilizing generative AI. The Medical Diagnostics segment sees the highest use of AI, making up 36% of AI-enabled cardiovascular ventures.
4. Global Cardiovascular Partnerships in Digital Health: Cardiovascular health ventures captured 11% of all digital health partnerships worldwide in 2024, underscoring robust corporate and academic interest in digital health solutions for heart health.
5. Clinical Evidence for Cardiovascular Digital Health Outcomes: Nearly half (47%) of cardiovascular digital health ventures demonstrate strong evidence for improving patient outcomes, with 79% of clinical trial-focused ventures showing significant effectiveness.

This report is powered by HealthTech Alpha, a leading provider of comprehensive data and insights in the digital health sector. With a focus on the evolving landscape of healthcare technology, HealthTech Alpha harnesses its extensive database and expertise to analyze trends and innovations that are shaping the future of medtech. By leveraging robust data analytics and market intelligence, HealthTech Alpha enables stakeholders—from investors to medical device manufacturers—to make informed decisions and strategically navigate the complexities of digital transformation in healthcare. Through this collaboration, the report offers valuable perspectives on the intersection of digital health and medtech, equipping readers with the knowledge to understand and engage with this rapidly changing industry.

Digital Health ventures and companies featured in this report: Brainomix, SOPHiA GENETICS, Anumana, Lark Health, Huma, Karius, Kestra Medical Technologies, Eko Health, CENTOGENE, Octagos Health, HeartFlow, RapidAI, Covera Health, Flosonics Medical , Elucid, Genomics PLC , Volta Medical, BioSerenity, MiRXES, HealthifyMe, Sky Labs (스카이랩스), AstraZeneca, Johnson & Johnson, Novartis, Roche, Bayer, Bristol Myers Squibb,